Abstract
Background
Silicone implant breast augmentation has been routinely performed since the 1960s. Emerging literature suggests the existence of a clinical syndrome, silicone implant incompatibility syndrome (SIIS) resulting from silicone implants. Autoimmune reactivity develops, with subsequent symptoms including myalgias, arthralgias, chronic fatigue, sleep disturbance and cognitive impairment. While the existence of a clinical entity is currently being established in the literature, there are currently no guidelines on management.
Method
Literature review was conducted using Medline and PubMed databases with key terms searched for, prior to hand-searching and bibliographical review until February 2019. The relevant literature was reviewed to determine whether consensus exists on the most appropriate management strategy.
Results
Forty-nine articles relevant to SIIS were identified with twenty-one of these specifically outlining treatment. Of these, only five provided data on larger cohorts, three provided conclusions from literature reviews, and the remainder were small case series or isolated case reports. Improvement in symptoms was obtained by medical management of their immune response, by explantation and by simply counselling on the condition itself.
Conclusions
A new clinical condition is being described that appears to suggest a link between silicone implant use and various symptoms in a cohort of patients. The subsequent treatment of SIIS is yet to be agreed upon. Further research is required to establish guidelines for diagnosis and ensure evidence-based treatment, and that patients and clinicians have a more refined understanding of the potential risks of silicone breast implant use.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00266-019-01407-4/MediaObjects/266_2019_1407_Fig1_HTML.png)
Similar content being viewed by others
References
Pavlov-Dolijanovic S, Vujasinovic Stupar N (2017) Women with silicone breast implants and autoimmune inflammatory syndrome induced by adjuvants: description of three patients and a critical review of the literature. Rheumatol Int 37(8):1405–1411
Jenkins ME, Friedman HI, von Recum AF (1996) Breast implants: facts, controversy, and speculations for future research. J Invest Surg 9(1):1–12
Peters W (1995) Silicone breast implants and autoimmune connective tissue disease. Ann Plast Surg 34(1):103–109
Gabriel SE et al (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 330(24):1697–1702
Spiera RF, Gibofsky A, Spiera H (1994) Silicone gel filled breast implants and connective tissue disease: an overview. J Rheumatol 21(2):239–245
Hirmand H, Latrenta GS, Hoffman LA (1993) Autoimmune disease and silicone breast implants. Oncology (Williston Park) 7(7):17–24 (discussion 24, 28, 30)
Shons AR, Schubert W (1992) Silicone breast implants and immune disease. Ann Plast Surg 28(5):491–499 (discussion 499–501)
Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36(1):4–8
Colaris MJL et al (2017) Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunol Res 65(1):120–128
Maijers MC et al (2013) Women with silicone breast implants and unexplained systemic symptoms: a descriptive cohort study. Neth J Med 71(10):534–540
Cohen Tervaert JW, Kappel RM (2013) Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res 56(2–3):293–298
Thomas WO 3rd et al (1997) Explantation of silicone breast implants. Am Surg 63(5):421–429
Rohrich RJ et al (2000) A prospective analysis of patients undergoing silicone breast implant explantation. Plast Reconstr Surg 105(7):2529–2537 (discussion 2538–2543)
Kappel RM, Cohen Tervaert JW, Pruijn GJ (2014) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) due to silicone implant incompatibility syndrome in three sisters. Clin Exp Rheumatol 32(2):256–258
Dagan A et al (2016) When uncommon and common coalesce: adult onset Still’s disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA). Clin Rheumatol 35(6):1643–1648
Kivity S et al (2012) Autoimmune syndrome induced by adjuvants (ASIA) in the Middle East: morphea following silicone implantation. Lupus 21(2):136–139
Genovese MC (1997) Fever, rash, and arthritis in a woman with silicone gel breast implants. West J Med 167(3):149–158
Nunes e Silva D et al (2017) Autoimmune syndrome induced by adjuvants (ASIA) after silicone breast augmentation surgery. Plas Reconstr Surg Glob Open 5(9):e1487
Mizuno Y et al (2018) Pleuritis and pericarditis following silicone breast implants as part of autoimmune syndrome induced by adjuvants. J Clin Rheumatol 24(7):404–406
Jara LJ et al (2012) Still’s disease, lupus-like syndrome, and silicone breast implants. A case of ‘ASIA’ (Shoenfeld’s syndrome). Lupus 21(2):140–145
Schierbeck J et al. (2017) Silicone implant incompatibility syndrome (SIIS) in a 57-year-old woman with unilateral silicone breast implant. BMJ Case Reports 2017
Katayama I, Umeda T, Nishioka K (1998) Adult Still’s-disease-like illness in a patient with silicone breast implants. Clin Rheumatol 17(1):81–82
Cretel E et al (2001) Still’s-like disease, breast prosthesis, and collagen implants. Rheumatol Int 20(3):129–131
Montalto M et al (2004) Systemic inflammatory diseases and silicone breast prostheses: report of a case of adult Still disease and review of the literature. Am J Med Sci 327(2):102–104
Blasiak A et al (2008) Still’s disease in patient with silicone breast implants: case report. Pol Arch Med Wewn 118(1–2):65–67
Cohen Tervaert JW, Colaris MJ, van der Hulst RR (2017) Silicone breast implants and autoimmune rheumatic diseases: myth or reality. Curr Opin Rheumatol 29(4):348–354
Watad A et al (2017) Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome)—an update. Lupus 26(7):675–681
Zazgornik J et al (1996) Autoimmune reactions in patients with silicone breast implants. Wien Klin Wochenschr 108(24):781–787
Goren I, Segal G, Shoenfeld Y (2015) Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk? Clin Rheumatol 34(10):1661–1666
Watad A et al (2018) The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol 37(2):483–493
Colaris MJL, van der Hulst RR, Tervaert JWC (2017) Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature. Clin Rheumatol 36(5):981–993
Nesher G et al (2015) Severe ASIA syndrome associated with lymph node, thoracic, and pulmonary silicone infiltration following breast implant rupture: experience with four cases. Lupus 24(4–5):463–468
Balk EM et al (2016) Long-term health outcomes in women with silicone gel breast implants: a systematic review. Ann Intern Med 164(3):164–175
Bar-Meir E, Eherenfeld M, Shoenfeld Y (2003) Silicone gel breast implants and connective tissue disease–a comprehensive review. Autoimmunity 36(4):193–197
Brown SL (2002) Epidemiology of silicone-gel breast implants. Epidemiology 13(Suppl 3):S34–S39
Brown SL, Langone JJ, Brinton LA (1988) Silicone breast implants and autoimmune disease. J Am Med Womens Assoc (1972) 53(1):21–24
Bridges AJ et al (1993) A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med 118(12):929–936
Peters W et al (1997) An outcome analysis of 100 women after explantation of silicone gel breast implants. Ann Plast Surg 39(1):9–19
Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342(11):781–790
Tang SY, Israel JS, Afifi AM (2017) Breast Implant Illness: symptoms, patient concerns, and the power of social media. Plast Reconstr Surg 140:765e–766e
Acknowledgements
The authors would like to thank Kathryn Rough, Northern Health Librarian, for her assistance in performing literature review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest to disclose.
Ethical Standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fuzzard, S.K., Teixeira, R. & Zinn, R. A Review of the Literature on the Management of Silicone Implant Incompatibility Syndrome. Aesth Plast Surg 43, 1145–1149 (2019). https://doi.org/10.1007/s00266-019-01407-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-019-01407-4